Russia
Russia’s Pharmaceutical market 2018
June 11 by Adam MusprattIs the Russian pharmaceutical market on course for rapid growth or will it devolve into a market plagued by staleness and drug shortages?
Ousted! How Sanctions against Russia Are Expected to Affect Pharma Investments
June 24 by Maxim SrajBetween 2010 and 2014, Russia’s pharma industry witnessed a record number of mergers, acquisitions and greenfield investments. However, recently enacted sanctions against the country have incr...
Infographic: Clinical Trial Supply USA
May 13 by Pharmaceuticals & Biotechnology EditorNearly a third of all respondents stated that CROs would be an area of active investment in the next 6 months. 50% of respondents will be running 6 or more clinical trials in the BRIC region. Read a...
It’s Time for the Pharmaceutical Industry to Redefine the Emerging Markets says Booz & Company’s Latest Study
March 27 by Pharma IQ NewsOne in every two top pharma company managers expects share of revenues coming from emerging markets to exceed 30% by 2018 Local idiosyncrasies make it essential to have bespoke approaches...
Do You Believe in the Domestic Pharma Industry?
May 25 by Pharma IQThe competitive growth of domestic pharma industry manufacturers has finally become one of the top-priority objectives for the next 8 years. The long-awaited WTO accession of Russia, requirements, l...
Celebrating International Clinical Trials Day: Starting with the Supply Chain
May 17 by Niamh MadiganInternational Clinical Trials' Day will be celebrated on the 20th of May in order to celebrate the day that James Lind started his famous trial on the 20th of May 1747. In a seri...
Survey: BRIC Clinical Trials: Opportunities and Challenges
April 27 by Pharma IQ SurveysTell us what you think about clinical trials in the BRIC region and you could win a VIP conference pass for one of our clinical trials events. This short survey is online and will only take 2 m...
BRIC Clinical Trials Report: Opportunities and Challenges
October 13 by Pharmaceuticals & Biotechnology EditorIndia is primed to become a hub for clinical research and clinical outsourcing activities. In a recent global study by Pharma IQ entitled “BRIC Clinical Trials: Opportunities and Challenges&rd...
Infographic: Phase I Clinical Trials European Update 2011
August 23 by Sumit DuttaEver wondered how many Phase I Clinical Trials are happening in Europe? This map gives a comprehensive overview of the phase I trials taking place in the EU. (click th...
Russia: Localisation vs. Isolation - Part Two
February 08 by Cyrus ChowdhuryPharma2020 – Towards Self-Reliance or the WTO? In late 2008, The Russian Federation’s Ministry of Industry and Trade announced the Pharma2020 strategy as part of the Healthcare Develo...
Russia: Localisation vs. Isolation - Part One
February 03 by Cyrus ChowdhuryThe Rise of Russia: Not Just a BRIC Anymore Five years ago, few pharmaceutical executives would have believed that 2011 would bring a feverish scramble to invest in Russia. At the time, many beli...
Distribution Practices in Russia
April 18 by Pharmaceuticals & Biotechnology EditorMikhail Khazanchuk, Quality and Compliance Manager, Russia and CIS, Johnson & Johnson, shares his insights on distribution practices in Russia & tips for overcoming related challenges.